Skip to main content
AAO-HNSF 2025 Annual Meeting & OTO EXPO Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Paul W. Gidley, MD

Professor
The University of Texas MD Anderson Cancer Center
Houston, Texas, United States

Paul W. Gidley, MD, FACS is a professor of Otology-Neurotology and Co-Director of the Skull Base Surgery Program in the Department of Head and Neck Surgery at UT MD Anderson Cancer Center. He graduated from Spring Hill College in Mobile, AL, majoring in Biology (cum laude) in 1986. He was elected Senior Class Orator and delivered the valedictory address. He attained his medical degree at University of Texas Medical School at Houston in 1990. He was elected into Alpha Omega Alpha. He completed his OTO-HNS residency at University of Texas at Houston in 1995. After completing his residency, he was hired as assistant professor at University of Texas Medical School at Houston. In 1996, he undertook a neurotology fellowship at University of Iowa under Drs. Bruce Gantz and Jay Rubinstein. He returned to Houston in 1997 as assistant professor at UT Houston Medical School for the next 6 years. He did a short stint in private practice in Houston from 2003 to 2006. He was recruited to join the Department of Head and Neck Surgery at UT MD Anderson by Dr. Randal Weber in 2006 as an Associate Professor; he has a joint appointment in the department of Neurosurgery. In 2012, he was promoted to Professor. Dr. Gidley has held several offices in local and state medical societies including President of Texas Association of Otolaryngology, President of Houston Society of Otolaryngology, and President of Central City Branch of the Harris County Medical Society. He has been involved in several committees of the AAO-HNS, and he has served on the Task Force for New Materials and as a senior examiner for the ABO.

His clinical practice covers all aspects of neurotology, but he specializes in temporal bone cancer and surgery for lateral and posterior fossa skull base tumors.

Disclosure information not submitted.

Presentation(s):